Award
National Heart, Lung, and Blood Institute 5U24HL147018-05
AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)
Recipient
Utah State Higher Education System--University of Utah
Award Amount
$561,423.00
Ceiling
$561,423.00
Awarded
November 26, 2024
Identifier
5U24HL147018-05
This award funds a clinical trial studying Azithromycin therapy in preschoolers with severe wheezing, aiming to improve treatment outcomes and understand microbial influences. The project is conducted at the University of Utah and funded by NHLBI.
Description
A multicenter clinical trial to evaluate the efficacy of Azithromycin in preschoolers with severe wheezing, determining if Azithromycin improves outcomes and if bacterial presence influences response. The project includes analysis of bacterial and viral prevalence, genetic factors, and microbial populations. Conducted at the University of Utah in Salt Lake City under NIH grant PAR-18-410.